SLNSW-Determining a Maximum-Tolerated Schedule of a Cyt...-TN_cdi_jstor_primary_3695952

Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent

Full title: Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent

Author/creator: Braun, Thomas M., Yuan, Zheng, Thall, Peter F..

Call Numbers:

Record Identifier: TN_cdi_jstor_primary_3695952

Language: English

Formats: Articles

Publishers: 350 Main Street , Malden , MA 02148 , U.S.A , and P.O. Box 1354, 9600 Garsington Road , Oxford OX4 2DQ , U.K: Blackwell Publishing

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_3695952

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent

    Record identifier

    TN_cdi_jstor_primary_3695952

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_3695952

    Share

    Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_3695952

    Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent

    Full title

    Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent

    Author / Creator

    Braun, Thomas M. ; Yuan, Zheng ; Thall, Peter F.

    Publisher

    350 Main Street , Malden , MA 02148 , U.S.A , and P.O. Box 1354, 9600 Garsington Road , Oxford OX4 2DQ , U.K: Blackwell Publishing

    Journal title

    Biometrics, 2005, Vol.61 (2), p.335-343

    Record Identifier

    TN_cdi_jstor_primary_3695952

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    A priori knowledge Administered dose Algorithms Biometrics Biometry - methods Bone Marrow Transplantation Clinical trials Clinical Trials, Phase I as Topic - methods Computer Simulation CRM Cytotoxins Data Interpretation, Statistical Dosage Dose escalation Dose-Response Relationship, Drug Experimentation Graft vs host disease Graft vs Host Disease - prevention & control Growth Substances - therapeutic use Humans Keratinocytes KGF Likelihood Functions Maximum Tolerated Dose Methods Models, Statistical Models, Theoretical Phase I clinical trials Phase I trial Proportional Hazards Models Recombinant Proteins - chemistry Statistical analysis Time Factors Toxicity Transplantation, Homologous

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_jstor_primary_3695952

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_3695952

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections